Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events - Sabatine, M S; Giugliano, R P; Wiviott, S DOpen-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators (N Engl J Med, 2015)
et al.